Structural basis of influenza virus neutralization
Identifieur interne : 000D13 ( Main/Exploration ); précédent : 000D12; suivant : 000D14Structural basis of influenza virus neutralization
Auteurs : Thomas Han [États-Unis] ; Wayne A. Marasco [États-Unis]Source :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 2011-01.
English descriptors
- Teeft :
- Acad, Acta virol, Amino, Amino acid changes, Amino acid variations, Amino acids, Antibody, Antibody neutralization, Antigenic, Antigenic drift, Antigenic shift, Antigenic sites, Antigenic structure, Antigenic variation, Antigenic variations, Avian, Avian viruses, Biol, Bnabs, Cancer immunology, Cancer institute, Carbonyl oxygen, Cell surface, Cleavage, Conformational changes, Crystal structures, Different subtypes, Endosomal membrane, Epitope, Fusion activity, Fusion peptide, Fusion peptide chain, Fusion process, Gene segments, Globular, Globular head, Globular head region, Haemagglutinin, Heavy chain, Helix, Hemagglutinin, Hemagglutinin figure, Hydrogen bond, Hydrophobic, Hydrophobic pocket, Immune, Immune responses, Immune system, Immunogen, Marasco, Marasco antibodies, Marasco figure, Membrane fusion, Monoclonal antibodies, Multiple subtypes, Mutant, Mutation, Nabs, Natural infection, Neutralization, Neutralization epitopes, Neutralizing, Neutralizing antibodies, Neutralizing antibody, Pandemic, Peptide, Plasma membrane, Population level, Proteolytic cleavage, Receptor, Receptor binding, Receptor binding region, Receptor binding site, Residue, Ribbon diagram, Same color, Seasonal vaccines, Side chain, Steric hindrance, Structural basis, Structural information, Subtypes, Subunit, Surface area, Universal vaccine, Vaccine, Vaccine immunogens, Vaccine strain selection, Vaccine strains, Vaccine strategies, Viral, Viral evolution, Virol, Virology, Virus, Virus entry, Virus evolution, Virus haemagglutinin, Virus hemagglutinin, Virus infectivity, Virus neutralization, Virus pathogenicity, Virus vaccine, York academy.
Abstract
Although seasonal influenza vaccines play a valuable role in reducing the spread of virus at the population level, ongoing viral evolution to evade immune responses remains problematic. No current vaccines elicit enduring protection in the face of emerging and re‐emerging influenza viruses that are rapidly undergoing antigenic drift. Eliciting broadly cross‐neutralizing antibody (nAb) responses against influenza virus is a crucial goal for seasonal and pandemic influenza vaccine preparation. Recent three‐dimensional structure information obtained from crystallization of influenza antigens in complex with nAbs has provided a framework for interpreting antibody‐based viral neutralization that should aid in the design of vaccine immunogens. Here, we will review current knowledge of the structure‐based mechanisms contributing to the neutralization and neutralization escape of influenza viruses. We will also explore the potential for this structure‐based approach to overcome the obstacles in developing the highly desired “universal” influenza vaccine.
Url:
- https://api.istex.fr/ark:/67375/WNG-333BFN1W-D/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062959
DOI: 10.1111/j.1749-6632.2010.05829.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000367
- to stream Istex, to step Curation: 000367
- to stream Istex, to step Checkpoint: 000134
- to stream Pmc, to step Corpus: 000550
- to stream Pmc, to step Curation: 000550
- to stream Pmc, to step Checkpoint: 000780
- to stream Ncbi, to step Merge: 000608
- to stream Ncbi, to step Curation: 000608
- to stream Ncbi, to step Checkpoint: 000608
- to stream Main, to step Merge: 000D18
- to stream Main, to step Curation: 000D13
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structural basis of influenza virus neutralization</title>
<author><name sortKey="Han, Thomas" sort="Han, Thomas" uniqKey="Han T" first="Thomas" last="Han">Thomas Han</name>
</author>
<author><name sortKey="Marasco, Wayne A" sort="Marasco, Wayne A" uniqKey="Marasco W" first="Wayne A." last="Marasco">Wayne A. Marasco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:57880EBAE12FE3A2EF1600A8DECAF26E7CD8B046</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1749-6632.2010.05829.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-333BFN1W-D/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000367</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000367</idno>
<idno type="wicri:Area/Istex/Curation">000367</idno>
<idno type="wicri:Area/Istex/Checkpoint">000134</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000134</idno>
<idno type="wicri:doubleKey">0077-8923:2011:Han T:structural:basis:of</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062959</idno>
<idno type="RBID">PMC:3062959</idno>
<idno type="wicri:Area/Pmc/Corpus">000550</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000550</idno>
<idno type="wicri:Area/Pmc/Curation">000550</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000550</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000780</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000780</idno>
<idno type="wicri:Area/Ncbi/Merge">000608</idno>
<idno type="wicri:Area/Ncbi/Curation">000608</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000608</idno>
<idno type="wicri:doubleKey">0077-8923:2011:Han T:structural:basis:of</idno>
<idno type="wicri:Area/Main/Merge">000D18</idno>
<idno type="wicri:Area/Main/Curation">000D13</idno>
<idno type="wicri:Area/Main/Exploration">000D13</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Structural basis of influenza virus neutralization</title>
<author><name sortKey="Han, Thomas" sort="Han, Thomas" uniqKey="Han T" first="Thomas" last="Han">Thomas Han</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Cancer Immunology and AIDS, Dana‐Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Marasco, Wayne A" sort="Marasco, Wayne A" uniqKey="Marasco W" first="Wayne A." last="Marasco">Wayne A. Marasco</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Cancer Immunology and AIDS, Dana‐Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Annals of the New York Academy of Sciences</title>
<title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint><biblScope unit="vol">1217</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="178">178</biblScope>
<biblScope unit="page" to="190">190</biblScope>
<biblScope unit="page-count">13</biblScope>
<publisher>Blackwell Publishing Inc</publisher>
<pubPlace>Malden, USA</pubPlace>
<date type="published" when="2011-01">2011-01</date>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term>
<term>Acta virol</term>
<term>Amino</term>
<term>Amino acid changes</term>
<term>Amino acid variations</term>
<term>Amino acids</term>
<term>Antibody</term>
<term>Antibody neutralization</term>
<term>Antigenic</term>
<term>Antigenic drift</term>
<term>Antigenic shift</term>
<term>Antigenic sites</term>
<term>Antigenic structure</term>
<term>Antigenic variation</term>
<term>Antigenic variations</term>
<term>Avian</term>
<term>Avian viruses</term>
<term>Biol</term>
<term>Bnabs</term>
<term>Cancer immunology</term>
<term>Cancer institute</term>
<term>Carbonyl oxygen</term>
<term>Cell surface</term>
<term>Cleavage</term>
<term>Conformational changes</term>
<term>Crystal structures</term>
<term>Different subtypes</term>
<term>Endosomal membrane</term>
<term>Epitope</term>
<term>Fusion activity</term>
<term>Fusion peptide</term>
<term>Fusion peptide chain</term>
<term>Fusion process</term>
<term>Gene segments</term>
<term>Globular</term>
<term>Globular head</term>
<term>Globular head region</term>
<term>Haemagglutinin</term>
<term>Heavy chain</term>
<term>Helix</term>
<term>Hemagglutinin</term>
<term>Hemagglutinin figure</term>
<term>Hydrogen bond</term>
<term>Hydrophobic</term>
<term>Hydrophobic pocket</term>
<term>Immune</term>
<term>Immune responses</term>
<term>Immune system</term>
<term>Immunogen</term>
<term>Marasco</term>
<term>Marasco antibodies</term>
<term>Marasco figure</term>
<term>Membrane fusion</term>
<term>Monoclonal antibodies</term>
<term>Multiple subtypes</term>
<term>Mutant</term>
<term>Mutation</term>
<term>Nabs</term>
<term>Natural infection</term>
<term>Neutralization</term>
<term>Neutralization epitopes</term>
<term>Neutralizing</term>
<term>Neutralizing antibodies</term>
<term>Neutralizing antibody</term>
<term>Pandemic</term>
<term>Peptide</term>
<term>Plasma membrane</term>
<term>Population level</term>
<term>Proteolytic cleavage</term>
<term>Receptor</term>
<term>Receptor binding</term>
<term>Receptor binding region</term>
<term>Receptor binding site</term>
<term>Residue</term>
<term>Ribbon diagram</term>
<term>Same color</term>
<term>Seasonal vaccines</term>
<term>Side chain</term>
<term>Steric hindrance</term>
<term>Structural basis</term>
<term>Structural information</term>
<term>Subtypes</term>
<term>Subunit</term>
<term>Surface area</term>
<term>Universal vaccine</term>
<term>Vaccine</term>
<term>Vaccine immunogens</term>
<term>Vaccine strain selection</term>
<term>Vaccine strains</term>
<term>Vaccine strategies</term>
<term>Viral</term>
<term>Viral evolution</term>
<term>Virol</term>
<term>Virology</term>
<term>Virus</term>
<term>Virus entry</term>
<term>Virus evolution</term>
<term>Virus haemagglutinin</term>
<term>Virus hemagglutinin</term>
<term>Virus infectivity</term>
<term>Virus neutralization</term>
<term>Virus pathogenicity</term>
<term>Virus vaccine</term>
<term>York academy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although seasonal influenza vaccines play a valuable role in reducing the spread of virus at the population level, ongoing viral evolution to evade immune responses remains problematic. No current vaccines elicit enduring protection in the face of emerging and re‐emerging influenza viruses that are rapidly undergoing antigenic drift. Eliciting broadly cross‐neutralizing antibody (nAb) responses against influenza virus is a crucial goal for seasonal and pandemic influenza vaccine preparation. Recent three‐dimensional structure information obtained from crystallization of influenza antigens in complex with nAbs has provided a framework for interpreting antibody‐based viral neutralization that should aid in the design of vaccine immunogens. Here, we will review current knowledge of the structure‐based mechanisms contributing to the neutralization and neutralization escape of influenza viruses. We will also explore the potential for this structure‐based approach to overcome the obstacles in developing the highly desired “universal” influenza vaccine.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Han, Thomas" sort="Han, Thomas" uniqKey="Han T" first="Thomas" last="Han">Thomas Han</name>
</region>
<name sortKey="Marasco, Wayne A" sort="Marasco, Wayne A" uniqKey="Marasco W" first="Wayne A." last="Marasco">Wayne A. Marasco</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:57880EBAE12FE3A2EF1600A8DECAF26E7CD8B046 |texte= Structural basis of influenza virus neutralization }}
This area was generated with Dilib version V0.6.33. |